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ACUTE VIRAL HEPATITIS
Clinical Course and Laboratory Aids in Diagnosis in Thirty-five Consecutive Cases
Adrenal Steroid Therapy in Seven Cases
HARVEY L . A T I N ,

M.D.*

Introduction:

The assertion has been made that the correct diagnosis of acute hepatitis can
be made at the bedside by means of a careful history and physical examination in
80 per cent of the patients who present themselves with this disease. With the aid of
appropriate laboratory studies this percentage can be increased to 90. The percentage
rises to 98 if liver biopsy is also employed.' Expectant treatment and observation
along with patience, will add to the accuracy of diagnosis still further. In an attempt
to assess the aid from laboratory diagnosis in this disease, and to evaluate the course
o\ the patient and response to treatment. 35 consecutive patients with viral hepatiti.^
and icterus were studied; these patients were admitted to the Henry Ford Hospita:
dm ing 1956 and 1957. There w as no evidence of underlying chronic liver disease
in this group. There were 22 males and 13 females and the cases were divided intr
those due to infectious hepatitis virus (IH) and those due to homologous serun
hepatitis virus (HSH). If the patient had received an injection from two weeks to
six months prior lo the ons'^l of his symptoms, he was considered to have serum
hepatitis; we realize that this is not necessarily true, as the IH virus can be transmitted also by the parenteral route. We arc also ayvare of the possibility that the IH
and HSH viruses are not necessarily separate strains.

The incubation period calculated from the time of the injection to the onset of
symptoms, in the HSH group, varied from 35 to 147 days with an average of 80 days.
The patient ranged from 8 to 67 years with an average age of 35 in the IH group
compared with 52 in the HSH group. Not only were the patients in the latter group
older, but the majority of them suffered from associated disease which necessitated
Ihe previous blood or parenteral medication. Whether due to these reasons or due
to the inherent greater virulence ot the B virus, as some have postulated, the patients
with serum hepatitis appear to suffer a more severe form of the disease, as the data
will indicate. It has long been said that scrum hepatitis has a more insidious onset,
and this mav be reflected in the longer duration of symptoms prior to admission, i.e..
13 5 compared with 9.9 days.
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Results:

Many different methods could have been used to evalute the laboratory data.
I he melhod used here was to record the peak abnormality, if any, and determine the
number of days this occurred from the onset of symptoms and from the date of
admission, and then note how long it look after onset of symptoms for this abnormality
lo return to normal. The data has been summarized in Table I .
•Kesutcnl. DiMsion of (iasiroenterolog\.
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Table I
Peak values of laboratory tests in 35 patients with viral hepatitis.
V I R A L HEPATITIS
35 Patients; 22 Males. 13 Females
IH
19

HSH
16

Age (yrs.)

8 - 66 (Av. 35)

20 - 67 (Av. 52)

Symptoms Prior to Admission (days)

1 - 28 (Av. 9.9)

4 - 28 (Av. 13.5)

Bilirubin (mg.%)

2 - 15 (Av. 8.1)

6 - 46 (Av. 16.2)

White Blood Count (x 1000)

3.3-11 (Av. 5.6)

4.5 - 10.5 (Av. 8.0)

Ciiolesterol Esters ( % )

21 - 58 (Av. 41)

24 - 63 (Av. 39)

Prothrombin Time ( % )

Av. 91

Av. 82

2.6 - 15.1 (Av. 7.4)

5.0 - 20 (Av. 9.5)

Number of Patients

Alkaline Phosphatase (Bodansky units)
Flocculation Tests
Ceph. Choi. Flocculation

5/35 less than 3+ throughout course.

fliymol Flocculation

6/35 less than 3-|- throughout cour.se.

Thymol Turbidity (Units)

3/35 less than 4 throughout course.
Av. 13.4
Av. 11.9

Bilirubin:
In HSH the bilirubin peaks were generally much higher (reaching 46 mg. per
cent in one case) and, although generally occurring in the first week in the hospital,
frequently took much longer (up to 21 days after admission or 31st day of iflness).
In IH the peaks were lower, rarely over 12 mg. per cent, and usually but not invariably
occurred within the first week in the hospital.
While Blood Count:
In no patient was there a white blood count above 11,000. Sevaral patients had
white blood counts below 5,000, particularly in the IH group. The absence of prominent
leukopenia in the HSH may be due to the longer duration of the illness prior to
admission and testing. A white blood count of over 11,000 in uncomplicated viral
hepatitis is extremely unusual.
Cholesterol esters:
The esters were usually below 50 per cent in 2/3 of the patients. The sickest
patients usually had the lower values, but there is not enough data or correlation to
make any further statement in this regard.
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Proihiomhin

Time:

Tne lowest value was 41 per cent and only two patients had values below 55 per
cent. This should not detract from the great prognostic value of a markedly abnormal
prothrombin time in hepatitis. A value below 20 per cent is a grave sign of a severely
diseased liver.
.Alkaline Phosphatase:
There was great variability in the peak values obtained and the number of days
required for the peak to be reached. In 24 patients with two or more determinations,
five reached values greater than 12 Bodansky units, i.e., approximately 20 per cent
reached values in the range of so-called obstructive jaundice.
Flocculation Tests:
Approximately 17 per cent of the patients had one test negative and about
12 per cent had two out of the three tests negative throughout the course of the
illness. Only one patient, or about 3 per cent, had all tests negative throughout the
course of the illness. Two patients, or about 6 per cent, had all tests negative during
the first week in the hospital. Generally the cephalin cholesterol flocculation is the
lirst and the thymol turbidity the last of these tests to be elevated.
Serum Iron and Seruin Glutamic Oxtiloacetic Transaminase:
According to Rinaldo, in jaundiced patients, values of serum transaminase greater
than 250 units and serum iron greater than 200 micrograms are almost diagnostic
of hepatitis.' Both tests appear to be of particular value early in the disease. About
60 per cent of those tested reached serum transaminase levels greater than 250 units,
.md 33 per cent serum iron levels greater than 200 micrograms per cent. Since many
were admitted some time after the onset of the disease, these percentages are probably
far lower than the true yield. The transaminase value in those with serial tests reached
the peak about the 16th or 17th day of the illness or within the first week of hospitalization. Since elevated serum transaminase levels did occur in patients with the cholanuiolitic variety of hepatitis, a serum transaminase level greater than 250 units, even
in the presence of a high alkaline phosphata.se and negative flocculation tests, still points
strongly to the diagnosis of hepatitis.

Serum Protein:
1 olal serum proteins and A/ G ratios were done on many patients but were all
normal. This docs not detract from the value of low total protein and particularly
a low albumin as an indication of a poor prognosis in patients with hepatitis. Furthermore, although no electrophoretic data was obtained on our patients, it is worth
nientionini; that a rising gamma globulin is frequently associated with prolonged and
chronic hepalitis. while a markedly elevated alpha globulin level is usually indicative
of extra hepatic obstructive jaundice or metastatic disease in the liver, rather than
hepatitis.'
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iiliary drainage and Oral Cholecystograins:
There were nine biliary drainages performed. Five of these could be considered
abnormal by usual criteria, but only one had calcium bilirubinate pigment. In no
^e were there both cholesterol crystals and bilirubinate pigment. Three of these
nine cases had cholecystograms. Two of these confirmed negative biliary drainage
lindings. The other case yielded a negative cholecystogram in a patient with microcalculi in the biliary drainage. Of the five oral cholecystograms performed, (these
were performed when jaundice was minimal), onlv one patient had an abnormal
x-ray. That was a patient in whom calculi were demonstrated and who had classical
biliary colic while in hospital. It is difficult to draw any conclusions from this data
hut it is suspected that the biliary drainage must be interpreted with caution in patients
with hepatitis.
( •'iiiplete Suppression of Bile Flow:
Twenty-nine patients had urinary urobilinogen or stool bile examinations on one
more occasions. There were 13 patients or about 40 per cent who exhibited
complete suppression of bile flow at some time during their course. Five patients, or
It 16 per cent, had complete suppression for greater than 10 days. The longest
'd of complete suppression in this series was 17 days. The frequency of prolonged
biliary suppression in this series again calls to our atlcnlion the fact that suppression
for more than ten days does not preclude a diagnosis of hepatitis.
Liver Biopsy:
The histological features of viral hepatitis during Ihe acute stage can be simply
ilcseribed as variations and degree of two features: diffuse portal area exudate and
parenchymal cell injury.* The diffuse portal exudate usually consists of leukocytes
and a few eosinophiles. The parenchymal injury may he manifested by focal necrosis
and lymphocyte satellitosis, acidophilic bodies, balloon cells, distortion of liver columns
in the acute stage and by mitosis, pseudo-acini, lipofuscin pigment in Kupffer cells
and bile stasis in the subsiding stage. During the latter part of the illness, the portal
exudate and lipofuscin pigment may be the only evidence of liver pathology.
Liver biopsy has been said to be about 90 per cent effective in the differential
diagnosis of jaundice.* Of the 35 patients studied, ten or about 30 per cent, had
a liver biopsy performed. Almost all of the biopsies were done during the resolving
stage of the disease, and in only three, or less than 10 per cent, did they appear lo
be necessary for diagnosis. One biopsy revealed normal liver tissue. The other nine
"eie reported as showing hepatitis. All of these revealed periportal lymphocytes in
moderate numbers and a few leukocytes. Four revealed marked focal aggregations
of lymphocytes and a few leukocytes in the parenchyma. Only two revealed focal
necrosis of liver cells and a similar number showed marked cholestasis. In four patients,
there was evidence of liver cell regeneration. There was mild portal fibrosis in two
patients, both of whom had HSH with marked cholestasis. There was no evidence of
bile duct proliferation, bile lakes and feathery degeneration, so frequently seen in the
v-'Mrahepatic variety of obstructive jaundice.

64

Harvey L. Atin
Vt^^^^Treatn^ent. Course and Prognosis:
All of the patients were treated with high-protein, high-carbohydrate diets, vitamins,
and enforced bed rest, during the acute stage of the disease. Some received lipotropic
.igents. liver extract, and parenteral fluids, carbohydrates and vitamins, as necessary.
Two patients received steroids, and their course will he discussed later.
VIRAL

HEPATITIS
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Table I I
I aboratory and clinical course in days in 32 patients with acute hepatitis.

('ourse:
1 lom lable II we note again the increased severity of the disease in HSH
compared with IH. The bilirubin, transaminase and thymol turbidity peaks are
iisii.ilh reached in that order during the first week in the hospital. Towards the end
of the first week or the beginning of the second week in the hospital, the patient's
.ippctite and sense of well being begin to show a definite improvement. Transaminase
appears to be the first of the laboratory tests to return to normal (about 31 days
trom onset of symptoms) and a persistent elevation in this test usually indicates
continued hepatic disease. A secondary rise in the serum lransamina.se during the
recovery phase usually indicates a relapse, and heralds a prolonged or chronic disease.
Ihe hilinihm ,ind thymol turbidity take longer periods to reach normal levels. The
ihvmol turbidity is usually the last to return to normal, not doing so until usually
the latter part of the second month of the illness in the average case. It should be
realized, however, that the thymol turbidity may not return to normal for several
months alter all the other tests have done so. The total duration of the illness in the
.i\er.ige case is about eight weeks in uncomplicated infectious hepalitis. compared
with more than ten weeks in HSH.
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There were three patients who after one year continued to have elevated flocition tests and suggestive evidence at least of chronic hepatitis. This percentage
bout 10 per cent is higher than usually expected with this disease. If we omit the
padents suspected of having chronic hepatitis, we find that two. or six per cent
approximately, of the remaining 32 suffered mild transient relapses. This percentage
I imilar to that reported by Ducci.' No patient in this series died.
Although the laboratory is a useful tool in the diagnosis and treatment of viral
I atitis, it still remains bul an adjunct to the all important bedside wisdom that
c only be obtained by .seeing and talking to the patient.
^

ROID THERAPY
Of the patients seen at the Henry Ford Hospital with viral hepatitis about 60
per cent are males. During the past two years, seven cases have been treated with
si nds. Of these, six or 86 per cent were females. This appears to indicate the
II
se follows a more severe course in the female patient. Of the seven, three were
II cd with steroids because of delay in the onset of the recovery phase, i.e. persistent
sing bilirubin and transaminase peaks and persistent complete intrahepatic biliary
ol Liction. These patients, however, were reported as "feeling and eating well",
pr r lo the onset of steroids, and the steroids were used in an attempt to "break
III Ihe disease process". In an attempt to evaluate the course of this group, they
v
compared with three patients not treated with steroids, who had exhibited
complete intrahepatic biliary obstruction for more than ten days. From Table I I I ,
VIRAL HEPATITIS -THERAPY
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Table I I I
Compariiion of the courses of the steroid and non-steroid treated patients.
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we note that the two groups were similar with reference to transaminase peaks and
days of complete biliary obstruction. The only significant difference was that two
of the steroid group had exhibited transient lethargy five and seven days prior to its
use. This indicates to a certain extent a more serious clinical state and will be
commented upon later. The apparent lower bilirubin peaks in the steroid group mav
be due to the effect of steroids in lowering serum bilirubin. There was a definite
decrease in liver size and tenderness along with a 50-60 per cent drop in total serum
bilirubin within 72 hours of starting the steroids. This was associated with definitj
evidence of bilirubin in the stool within 48 hours. Although all patients in this group
were apparently feeling and eating well, there was a clearcut added surge of well
being, to the point of euphoria at times, and increased appetite, within 24 hours.
There is some evidence that steroids do decrease the inflammatory reaction in the
liver, and may improve bile flow by this method.' There is, however, some other
unknown mechanism by which the serum bilirubin level is lowered, since this occurs
even though bile flow obstruction persists, as noted in the fourth case. The longer
period of transaminase elevation in the treated group indicates these drugs do not
prevent continued hepatic cell injury and this point should be kept in mind when
considering their use in the hepatic coma of viral hepatitis. In spite of the sudden
prompt drop in bilirubin with the use of steroids, there is apparently no significant
difference in Ihe period required for the total bilirubin to return to normal or in the
total duration of the illness in the two groups. Doses of 300-400 mg. of cortisone,
or its equivalent dropped gradually over a period of 7-14 days to maintenance levels,
appears to be adequate when these drugs are used for the reasons described above.
There was one mild relapse in the control group and one relapse with prolonged
recovery in the steroid group. Recrudescences can develop in both groups and occur
while the dose is being decreased or at termination of therapy in the steroid group.
The reported relapse rate is about 20 per cent in the steroid treated group and about
5 per cent in those not treated with steroids.'
A fourth patient has been grouped separately. Her disease began in a mild
manner about five weeks before. She had carried out strenuous activity during this
period, and from her history we considered her to have a severe exacerbation of the
disease. While in hospital her appetite and well being decreased and bile disappeared
from the stool. Her sensorium. however, remained good. Because of the progressive
nature of the disease, she was started on 400 mg. of cortisone daily. The total serum
bilirtibin eiroppcd from 27 to 21 mg. and her appetite and weW being improved within
72 hours. Bilirubin continued to be absent in the stool for the next 14 days, however,
and no further drop in total serum bilirubin occurred during this time. Once the
bilirubin began to appear in Ihe stool the serum bilirubin gradually decreased. After
three weeks the patient is still on 200 mg. of cortisone daily and continues to gradually
improve, although her progress has been slightly marred by transient hypomania and
persisting euphoria. The early mild fall in serum bilirubin probably had nothing to
do with hepatic function. The persistent absence of bilirubin in the stool and absence
of progressive fall in serum bilirubin over two weeks can be considered as a partial
tailure of steroid therapy.
The other three patients who were treated with steroids exhibited progressive
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idence of liver decompensation, manifested by lethargy and restlessness, decreasing
\ ;11 being, appetite, albumin, prothrombin and cholesterol esters, and increasing
bilirubin and transaminase. They could be classed as the pre-coma stage of liver
, compensation.
Two of these were started on what might be considered average doses of steroids,
that is, 400 mg. or less of cortisone or its equivalent. Both exhibited transient improvement in appetite, sensorium and general well being. In one patient, this lasted
only 24 hours and the patient subsequently expired on the twelfth day of steroids,
despite antibiotics and arginine. This patient had exhibited progressive lethargy for
three days, ascites, shrinking liver, and abdominal distention prior to the use of
steroids. At post mortem, the patient was found to have diffuse and almost total
hepatic necrosis and superficial gastric ulcers, with moderately severe upper gastrointestinal bleeding. The possible role of the steroids in the GI bleeding is of interest,
but any answer at present can only be speculative in this regard. The other patient
had a fluctuant course with ups and downs of lethargy, state of appetite, and well
being for five days prior to steroids. She showed a good response to steroid therapy
with marked increase in well being, sensorium, and appetite within 24 hours, and
clearing of the obstructive phase with a 60 per cent drop in bilirubin within 72 hours.
After 11 days of steroids, when the dose of cortisone was down to 50 mg. daily, she
developed a relapse, associated with decreased appetite and well being, rising bilirubin
and transaminase, and recurrence of the obstructive phase. The dose was then increased
to 800 mg. daily with increase in appetite and well being and cessation of the
obstructive phase within 72 hours. The transaminase, which after rising had begun
to fall prior to the increase in dosage, continued to fall to normal levels in an uninterrupted fashion. The serum bilirubin level, however, remained elevated without
significant change for almost three weeks. The total serum protein continued to fall
to a low of 4.8 grams per cent over the next two weeks, in spite of doses of cortisone
ranging from 800 to 400 mg. daily. After five weeks on high doses of cortisone, only
complicated by mild depression and homesickness, the patient was discharged on
200 mg. of cortisone, eating well, with increasing energy, but still manifesting visible
but mild icterus. Although the cortisone resulted in clinical improvement and appeared
to stop and reverse the clinical downward trend of the illness, it did not result in
sufficient laboratory evidence to indicate improvement in hepatic function and was
associated with a clinical exacerbation when the dose was being lowered.
The third patient treated in the pre-coma stage was started on 800 mg. of
cortisone daily. She had exhibited progressive hepatic deterioration at another hospital
in spite of 15 mg. of meticorten daily. When first seen at Henry Ford Hospital, a
"hepatic flap" could already be demon.strated. There was no change in the downhill
course with increase in steroid dosage and the patient expired several days later. A
request for post mortem examination was denied.
The work of Ducci indicating the value of high doses of cortisone (1 gram of
cortisone or its equivalent) in hepatic coma due to viral hepatitis has been an
important contribution to the treatment of this almost invariably fatal situation.
Evidence to date, however, indicates that lower, more average do.ses of these steroids
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will not alter the outcome of the patient in the coma stage. The doses appreniK
must be high. I urihermore. Ihe earlier the steroids are used, the greater the chance
of survival. The importance of low albumin and prothrombin levels as indicators ol
hepatic disease does not require re-emphasis al this time. It is interesting to note, howe\er. that only two patients in the original series of 35 exhibited lethargy and both of
these received steroids later, after Ihe lethargy had cleared, but when they exhibited a
failure lo enter Ihe recovery stage of the ailment. Since lethargy occurs when the
liver is severely diseased and had appeared from three to seven days prior to the date
of beginning of steroid therapv in five out of seven of our patients, we may in thi;
sign find one of the important indicators for those patients who should receive steroids
ll is. therefore, suggested that any lethargy, severe enough to be clinically evident
sluHild be met wilh steroid therapy. The dose at this point should be about 400 mg
of cortisone daily or its equivalent. If the lethargy progresses or clinical state remain,
stationary after 48 hours, then Ihe daily dose should be increased to 800 lo 1000 mg.
Conclusions:
From the work lo dale. Ihe routine use of steroids in acute, benign, viral hepatitis
seems inadvisable.' Its use in the patient wilh persistent, complete, intrahepatic biliar.
obstruction or cholangiolilic hepatitis is open lo question. If Ihe patient appears to
be handling the elisease well in spile of the absence of bilirubin in the stool, since we
ire probably not improving liver function or shortening significantly the total duratio.i
of the illness with the use of these drugs, the decision lo employ them must be
weighed very carefully. The possibility of untoward effects of steroid therapy along
with a false sense of improvement must be weighed against Ihe possible good results
of their use.
Steroid therapy does dcfinitcb appear lo be indicated in Ihe patient with prolonged
and/or progressive liver disease elite to acute viral hepatitis. The patient's ability to
handle and respond to the disease appears to be the prime consideration here. The
important factor is the patient himselL and the decision to use steroids must he made
ll the bedside where clinical judgment must take precedence over results of laboratory
tests. The use of steroids in the pre-coma and coma stages of acute hepatitis has
already been discussed and appears well established al present.
I he lendencN fe^r the disease to run a more severe course in the female and the
ellectiveness of steroids in many severely ill patients with acute hepatitis brings into
locus once more the interrelationship of the cndocrines and the liver. Would the
use of steroids, other than ailrenal. e.g. androgens, be more effectual in the treatment
ot viral hepatitis'.'
SUMMARY:
I hirlv-five consecutive cases of acute viral hepatitis have been studied in an
attempt lo determine the averiige clinical and laboratory course of the disease. The
l.iboralorv tests iisetul in iliagnosis and in following the course of the disease are
siresseil.
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Seven cases of acute viral hepatitis treated with steroids are carefully evaluated
d the relative value of these agents under various circumstances is discussed.
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